Your search returned 2 results.

Results
	1.	Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial. [electronic resource] by Dignass, Axel Stoynov, Simeon Dorofeyev, Andrey E Grigorieva, Galina A Tomsová, Eva Altorjay, István Tuculanu, Daniel Bunganič, Ivan Pokrotnieks, Juris Kupčinskas, Limas Dilger, Karin Greinwald, Roland Mueller, Ralph Producer: 20150514 In: Journal of Crohn's & colitis vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. [electronic resource] by Tromm, Andreas Bunganič, Ivan Tomsová, Eva Tulassay, Zsolt Lukáš, Milan Kykal, Jan Bátovský, Marian Fixa, Bohumil Gabalec, Libor Safadi, Rifaat Kramm, Heinz-Jochen Altorjay, István Löhr, Hanns Koutroubakis, Ioannis Bar-Meir, Simon Stimac, Davor Schäffeler, Elke Glasmacher, Christoph Dilger, Karin Mohrbacher, Ralf Greinwald, Roland Producer: 20110328 In: Gastroenterology vol. 140 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search